BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29466862)

  • 1. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
    Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
    Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan Africa.
    Boyd A; Kouamé MG; Houghtaling L; Moh R; Gabillard D; Maylin S; Abdou Chekaraou M; Delaugerre C; Anglaret X; Eholié SP; Danel C; Zoulim F; Lacombe K;
    Trans R Soc Trop Med Hyg; 2019 Aug; 113(8):437-445. PubMed ID: 31574151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4
    Kouamé GM; Gabillard D; Moh R; Badje A; Ntakpé JB; Emième A; Maylin S; Toni TD; Ménan H; Zoulim F; Danel C; Anglaret X; Eholié S; Lacombe K; Boyd A
    Antivir Ther; 2021; 26(1-2):25-33. PubMed ID: 35485344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
    Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
    BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D; Ankcorn M; Sarfo F; Phillips R; Fox Z; Garcia A; Appiah L; Bedu-Addo G; Geretti AM
    J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study.
    Silva CMD; Peder LD; Silva ES; Previdelli I; Pereira OCN; Teixeira JJV; Bertolini DA
    J Infect Dev Ctries; 2018 Nov; 12(11):1009-1018. PubMed ID: 32012132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
    Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J;
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire.
    N'Dri-Yoman T; Anglaret X; Messou E; Attia A; Polneau S; Toni T; Chenal H; Seyler C; Gabillard D; Wakasugi N; Eholié S; Danel C
    Antivir Ther; 2010; 15(7):1029-34. PubMed ID: 21041918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa.
    Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Danel C; Delaugerre C; Zoulim F; Lacombe K;
    Liver Int; 2019 Feb; 39(2):280-289. PubMed ID: 30257068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients.
    Arendt E; Jaroszewicz J; Rockstroh J; Meyer-Olson D; Zacher BJ; Mederacke I; Manns MP; Wedemeyer H; Cornberg M; Wursthorn K
    Viral Immunol; 2012 Dec; 25(6):442-7. PubMed ID: 23131018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy.
    Christian B; Fabian E; Macha I; Mpangala S; Thio CL; Ulenga N; Mugusi F; Ammerman LR; Fawzi W; Green R; Murphy R; Hawkins C
    AIDS; 2019 Mar; 33(3):465-473. PubMed ID: 30702515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.
    Weissmann L; Picone CM; Gouvêa MSG; Ferreira PRA; Viana MSVB; Pinho JRR; Cassenote AJF; Segurado AC
    Braz J Infect Dis; 2019; 23(6):441-450. PubMed ID: 31715124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.